|
1
|
Lopez E and Jamison M: Global Burden of
Disease and Risk Factors: Disease Control Priorities Project. World
Bank and Oxford University Press. New York, NY: 2006. View Article : Google Scholar
|
|
2
|
Davies MJ and Thomas AC: Plaque fissuring
- the cause of acute myocardial infarction, sudden ischaemic death,
and crescendo angina. Br Heart J. 53:363–373. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakowicz A, Fendler W, Lelonek M and
Pietrucha T: Genetic variability and the risk of myocardial
infarction in Poles under 45 years of age. Arch Med Sci. 6:160–167.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goyette P, Pai A, Milos R, Frosst P, Tran
P, Chen Z, Chan M and Rozen R: Gene structure of human and mouse
methylenetetrahydrofolate reductase (MTHFR). Mamm Genome.
9:652–656. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rozen R: Genetic predisposition to
hyperhomocysteinemia: Deficiency of methylenetetrahydrofolate
reductase (MTHFR). Thromb Haemost. 78:523–526. 1997.PubMed/NCBI
|
|
6
|
Kutzbach C and Stokstad EL: Mammalian
methylenetetrahydrofolate reductase. Partial purification,
properties, and inhibition by S-adenosylmethionine. Biochim Biophys
Acta. 250:459–477. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma J, Stampfer MJ, Giovannucci E, Artigas
C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH and Rozen
R: Methylenetetrahydrofolate reductase polymorphism, dietary
interactions, and risk of colorectal cancer. Cancer Res.
57:1098–1102. 1997.PubMed/NCBI
|
|
8
|
Rosenblatt DS: Inherited disorders of
folate transport and metabolism. The Metabolic and Molecular Bases
of Inherited Disease. Scriver CR, Beaudet AL, Sly WS and Valle D:
McGraw-Hill Inc. (New York, NY). 3111–3128. 1995.
|
|
9
|
Skibola CF, Smith MT, Kane E, Roman E,
Rollinson S, Cartwright RA and Morgan G: Polymorphisms in the
methylenetetrahydrofolate reductase gene are associated with
susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA.
96:12810–12815. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guenther BD, Sheppard CA, Tran P, Rozen R,
Matthews RG and Ludwig ML: The structure and properties of
methylenetetrahydrofolate reductase from Escherichia coli
suggest how folate ameliorates human hyperhomocysteinemia. Nat
Struct Biol. 6:359–365. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang SS, Wong PW, Susmano A, Sora J,
Norusis M and Ruggie N: Thermolabile methylenetetrahydrofolate
reductase: An inherited risk factor for coronary artery disease. Am
J Hum Genet. 48:536–545. 1991.PubMed/NCBI
|
|
12
|
Poort SR, Rosendaal FR, Reitsma PH and
Bertina RM: A common genetic variation in the 3′-untranslated
region of the prothrombin gene is associated with elevated plasma
prothrombin levels and an increase in venous thrombosis. Blood.
88:3698–3703. 1996.PubMed/NCBI
|
|
13
|
Rosendaal FR, Siscovick DS, Schwartz SM,
Psaty BM, Raghunathan TE and Vos HL: A common prothrombin variant
(20210 G to A) increases the risk of myocardial infarction in young
women. Blood. 90:1747–1750. 1997.PubMed/NCBI
|
|
14
|
Doggen CJ, Cats VM, Bertina RM and
Rosendaal FR: Interaction of coagulation defects and cardiovascular
risk factors: Increased risk of myocardial infarction associated
with factor V Leiden or prothrombin 20210A. Circulation.
97:1037–1041. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Franco RF, Trip MD, ten Cate H, van den
Ende A, Prins MH, Kastelein JJ and Reitsma PH: The 20210 G––>A
mutation in the 3′-untranslated region of the prothrombin gene and
the risk for arterial thrombotic disease. Br J Haematol. 104:50–54.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ridker PM, Hennekens CH and Miletich JP:
G20210A mutation in prothrombin gene and risk of myocardial
infarction. Circulation. 99:999–1004. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brown K, Luddington R, Williamson D, Baker
P and Baglin T: Risk of venous thromboembolism associated with a G
to A transition at position 20210 in the 3′-untranslated region of
the prothrombin gene. Br J Haematol. 98:907–909. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Makris M, Preston FE, Beauchamp NJ, Cooper
PC, Daly ME, Hampton KK, Bayliss P, Peake IR and Miller GJ:
Co-inheritance of the 20210A allele of the prothrombin gene
increases the risk of thrombosis in subjects with familial
thrombophilia. Thromb Haemost. 78:1426–1429. 1997.PubMed/NCBI
|
|
19
|
Arruda VR, Annichino-Bizzacchi JM,
Gonçalves MS and Costa FF: Prevalence of the prothrombin gene
variant (nt20210A) in venous thrombosis and arterial disease.
Thromb Haemost. 78:1430–1433. 1997.PubMed/NCBI
|
|
20
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frosst P, Blom HJ, Milos R, Goyette P,
Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA,
van den Heuvel LP, et al: A candidate genetic risk factor for
vascular disease: A common mutation in methylenetetrahydrofolate
reductase. Nat Genet. 10:111–113. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Danneberg J, Abbes AP, Bruggeman BJ, Engel
H, Gerrits J and Martens A: Reliable genotyping of the G-20210-A
mutation of coagulation factor II (prothrombin). Clin Chem.
44:349–351. 1998.PubMed/NCBI
|
|
23
|
Cushman M: Hemostatic risk factors for
cardiovascular disease. Hematology. Schechter GP, Hoffman R and
Schrirer SL: The American Society of Haematology. (Washington, DC).
236–242. 1999.
|
|
24
|
Ridker PM: Fibrinolytic and inflammatory
markers for arterial occlusion: The evolving epidemiology of
thrombosis and hemostasis. Thromb Haemost. 78:53–59.
1997.PubMed/NCBI
|
|
25
|
Grant PJ: Polymorphisms of
coagulation/fibrinolysis genes: Gene environment interactions and
vascular risk. Prostaglandins Leukot Essent Fatty Acids.
57:473–477. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Di Minno G, Grandone E and Margaglione M:
Clinical relevance of polymorphic markers of arterial thrombosis.
Thromb Haemost. 78:462–466. 1997.PubMed/NCBI
|
|
27
|
Jukic I, Bingulac-Popovic J, Dogic V,
Hecimovic A, Babic I, Batarilo I, Maglov C and Sturm D: Evaluation
of ABO blood groups as a risk factor for myocardial infarction.
Blood Transfus. 11:464–465. 2013.PubMed/NCBI
|
|
28
|
Dikmen M, Ozbabalik D, Gunes HV,
Degirmenci I, Bal C, Ozdemir G and Basaran A: Acute stroke in
relation to homocysteine and methylenetetrahydrofolate reductase
gene polymorphisms. Acta Neurol Scand. 113:307–314. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Girelli D, Friso S, Trabetti E, Olivieri
O, Russo C, Pessotto R, Faccini G, Pignatti PF, Mazzucco A and
Corrocher R: Methylenetetrahydrofolate reductase C677T mutation,
plasma homocysteine, and folate in subjects from northern Italy
with or without angiographically documented severe coronary
atherosclerotic disease: Evidence for an important
genetic-environmental interaction. Blood. 91:4158–4163.
1998.PubMed/NCBI
|
|
30
|
Klerk M, Verhoef P, Clarke R, Blom HJ, KOK
FJ, Schouten EG, et al: MTHFR 677C––>T polymorphism and risk of
coronary heart disease: a meta-analysis. JAMA. 288:2023–2031. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Akar N, Akar E, Akçay R, Avcu F, Yalcin A
and Cin S: Effect of methylenetetrahydrofolate reductase 677 C-T,
1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep
vein thrombosis patients. Thromb Res. 97:163–167. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Spiroski I, Kedev S, Antov T, Krstevska M,
Dzhekova-Stojkova S, Kostovska S, Trajkov D, Petlichkovski A,
Strezova A, et al: Association of methylenetetrahydrofolate
reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with
occlusive artery disease and deep venous thrombosis in Macedonians.
Croat Med J. 49:39–49. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grandone E, Corrao AM, Colaizzo D,
Vecchione G, Di Girgenti C, Paladini D, Sardella L, Pellegrino M,
Zelante L, Martinelli P, et al: Homocysteine metabolism in families
from southern Italy with neural tube defects: Role of genetic and
nutritional determinants. Prenat Diagn. 26:1–5. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cesari M, Zanchetta M, Burlina A, Pedon L,
Maiolino G, Sticchi D, Pessina AC and Rossi GP:
Hyperhomocysteinemia is inversely related with left ventricular
ejection fraction and predicts cardiovascular mortality in
high-risk coronary artery disease hypertensives. Arterioscler
Thromb Vasc Biol. 25:115–121. 2005.PubMed/NCBI
|
|
35
|
Papoutsakis C, Yiannakouris N, Manios Y,
Papaconstantinou E, Magkos F, Schulpis KH, Zampelas A and Matalas
AL: Plasma homocysteine concentrations in Greek children are
influenced by an interaction between the methylenetetrahydrofolate
reductase C677T genotype and folate status. J Nutr. 135:383–388.
2005.PubMed/NCBI
|
|
36
|
Zuntar I, Topić E, Vukosavić D, Vuković V,
Demarin V, Begonja A, Antoljak N and Simundić AM: Croatian
population data for the C677T polymorphism in
methylenetetrahydrofolate reductase: Frequencies in healthy and
atherosclerotic study groups. Clin Chim Acta. 335:95–100. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xuan C, Li H, Zhao JX, Wang HW, Wang Y,
Ning CP, Liu Z, Zhang BB, He GW and Lun LM: Association between
MTHFR polymorphisms and congenital heart disease: A meta-analysis
based on 9,329 cases and 15,076 controls. Sci Rep. 4:73112014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Balogh E, Bereczky Z, Katona E, Koszegi Z,
Edes I, Muszbek L and Czuriga I: Interaction between homocysteine
and lipoprotein(a) increases the prevalence of coronary artery
disease/myocardial infarction in women: A case-control study.
Thromb Res. 129:133–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iqbal MP, Fatima T, Parveen S, Yousuf FA,
Shafiq M, Mehboobali N, Khan AH, Azam I and Frossard PM: Lack of
association of methylenetetrahydrofolate reductase 677C>T
mutation with coronary artery disease in a Pakistani population. J
Mol Genet Med. 1:26–32. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Alfirevic Z, Simundic A-M, Nikolac N,
Sobocan N, Alfirevic I, Stefanovi M, Vucicevic Z and Topic E:
Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and
PAI-1 5G/4G polymorphism in patients with venous thromboembolism:
Croatian case-control study. Biochem Med. 20:229–235. 2010.
View Article : Google Scholar
|
|
41
|
Mamasoula C, Prentice RR, Pierscionek T,
Pangilinan F, Mills JL, Druschel C, Pass K, Russell MW, Hall D,
Töpf A, et al: Association between C677T polymorphism of methylene
tetrahydrofolate reductase and congenital heart disease:
meta-analysis of 7697 cases and 13,125 controls. Circ Cardiovasc
Genet. 6:347–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Keijzer MB, Borm GF, Blom HJ, Bos GM,
Rosendaal FR and den Heijer M: No interaction between factor V
Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous
thrombosis. Results of a meta-analysis of published studies and a
large case-only study. Thromb Haemost. 97:32–37. 2007.PubMed/NCBI
|
|
43
|
Lewis SJ, Ebrahim S and Smith Davey G:
Meta-analysis of MTHFR 677C->T polymorphism and coronary heart
disease: Does totality of evidence support causal role for
homocysteine and preventive potential of folate? BMJ. 331:10532005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li YY: Methylenetetrahydrofolate reductase
C677T gene polymorphism and coronary artery disease in a Chinese
Han population: A meta-analysis. Metabolism. 61:846–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xuan C, Bai XY, Gao G, Yang Q and He GW:
Association between polymorphism of methylenetetrahydrofolate
reductase (MTHFR) C677T and risk of myocardial infarction: A
meta-analysis for 8,140 cases and 10,522 controls. Arch Med Res.
42:677–685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lane DA, Philippou H and Huntington JA:
Directing thrombin. Blood. 106:2605–2612. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kapur RK, Mills LA, Spitzer SG and Hultin
MB: A prothrombin gene mutation is significantly associated with
venous thrombosis. Arterioscler Thromb Vasc Biol. 17:2875–2879.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ercan B, Tamer L, Sucu N, Pekdemir H,
Camsari A and Atik U: Factor VLeiden and prothrombin G20210A gene
polymorphisms in patients with coronary artery disease. Yonsei Med
J. 49:237–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gohil R, Peck G and Sharma P: The genetics
of venous thromboembolism. A meta-analysis involving approximately
120,000 cases and 180,000 controls. Thromb Haemost. 102:360–370.
2009.PubMed/NCBI
|
|
50
|
Watzke HH, Schüttrumpf J, Graf S, Huber K
and Panzer S: Increased prevalence of a polymorphism in the gene
coding for human prothrombin in patients with coronary heart
disease. Thromb Res. 87:521–526. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ferraresi P, Marchetti G, Legnani C,
Cavallari E, Castoldi E, Mascoli F, Ardissino D, Palareti G and
Bernardi F: The heterozygous 20210 G/A prothrombin genotype is
associated with early venous thrombosis in inherited thrombophilias
and is not increased in frequency in artery disease. Arterioscler
Thromb Vasc Biol. 17:2418–2422. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Corral J, Gonzalez-Conejero R, Lozano ML,
Rivera J, Heras I and Vicente V: The venous thrombosis risk factor
20210 A allele of the prothrombin gene is not a major risk factor
for arterial thrombotic disease. Br J Haematol. 99:304–307. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ridker PM, Hennekens CH and Miletich JP:
G20210A mutation in prothrombin gene and risk of myocardial
infarction, stroke, and venous thrombosis in a large cohort of US
men. Circulation. 99:999–1004. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Makris TK, Krespi PG, Hatzizacharias AN,
Gialeraki AE, Anastasiadis G, Triposkiadis FK, Mandalaki T and
Kyriakidis MK: Resistance to activated protein C and FV leiden
mutation in patients with a history of acute myocardial infarction
or primary hypertension. Am J Hypertens. 13:61–65. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Burzotta F, Paciaroni K, De Stefano V,
Chiusolo P, Manzoli A, Casorelli I, Leone AM, Rossi E, Leone G,
Maseri A, et al: Increased prevalence of the G20210A prothrombin
gene variant in acute coronary syndromes without metabolic or
acquired risk factors or with limited extent of disease. Eur Heart
J. 23:26–30. 2002. View Article : Google Scholar : PubMed/NCBI
|
